Corcept Therapeutics CORT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's net margin?
- Corcept Therapeutics (CORT) reported net margin of 6.2% in Q1 2026.
- How has Corcept Therapeutics's net margin changed year-over-year?
- Corcept Therapeutics's net margin decreased by 68.5% year-over-year, from 19.5% to 6.2%.
- What is the long-term trend for Corcept Therapeutics's net margin?
- Over 5 years (2020 to 2025), Corcept Therapeutics's net margin has grown at a -15.3% compound annual growth rate (CAGR), from 30% to 13.1%.
- What does net margin mean?
- The share of every sales dollar that becomes bottom-line profit.
- How do you interpret net margin?
- Higher is better, but net margin mixes operating performance with financing and tax effects and one-off items — read it alongside operating margin to separate the operating story from the rest.
- How does net margin compare across companies?
- Comparable across peers but sensitive to leverage and tax structure; two operationally identical firms can show different net margins purely from financing.